Last updated on February 2018

ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)

Brief description of study

Diabetic and nondiabetic patients will be evaluated if they had a first diagnosis of non-valvular atrial fibrillation and in therapy with non-vitamin K oral anticoagulants and with vitamin K oral anticoagulants.

Detailed Study Description

Parameters evaluated:

  • anthropometric indices
  • glycated haemoglobin, basal and postprandial glycemia
  • lipid profile
  • small and dense LDL; oxidized LDL
  • I troponin
  • red and white cells count; platelets count
  • creatinin, transaminases, iron
  • fibrinogen, D-dimer, anti-thrombin III
  • Hs-CRP, metalloproteinases 2 and 9
  • incidence of bleeding

Clinical Study Identifier: NCT02935855

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.